HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells

Oncotarget

Volumn 4, Issue 2, 2013, Pages 192-205

  Purpura, Valeria ^a   Belleudi, Francesca ^a   Caputo, Silvia ^a   Torrisi, Maria Rosaria ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Differentiation; FGFR2b; HPV16 E5; Human keratinocytes; KGFR

Indexed keywords

CELL MARKER; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 203; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN E5; PROTEIN K1; PROTEIN KINASE B; PROTEIN P63; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTRACELLULAR SIGNALING; KERATINOCYTE; MOLECULAR INTERACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CARCINOGENESIS;

EID: 84875791304     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.803     Document Type: Article

References (35)

1. Moody CA, Laimnins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-560.
2. Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G. Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer 2011; 10: 140.
3. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003; 22: 5201-5207.
4. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004; 68: 362-372.
5. Belleudi F, Leone L, Purpura V, Cannella F, Scrofani C, Torrisi MR. HPV16 E5 affects the KGFR/FGFR2bmediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic. Oncogene 2011; 30: 4963-4976.
6. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116-129.
7. Marchese C, Chedid M, Dirsch OR, Csaky KG, Santanelli F, Latini C, LaRochelle WJ, Torrisi MR, Aaronson SA. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 1995; 182: 1369- 76.
8. LaRochelle WJ, Dirsch OR, Finch PW, Cheon HG, May M, Marchese C, Pierce JH, Aaronson SA. Specific receptor detection by a functional keratinocyte growth factorimmunoglobulmn chimera. J Cell Biol 1995; 129: 357-366.
9. Capone A, Visco V, Belleudi F, Marchese C, Cardinali G, Bellocci; Picardo M, Frati L, Torrisi MR. Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ 2000; 11: 607-614.
10. Belleudi F, Purpura V, Torrisi MR. The receptor tyrosine kinase FGFR2b/KGFR controls early differentiation of human keratinocytes. PLoS One 2011; 6: e24194.
11. Feng S, Wang F, Matsubara A, Kan M, McKeehan W L. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 1997; 58: 1509-1514.
12. Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL, Okamoto T. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci USA 2001; 98: 11336-11340.
13. Grose R, Fantl V, Werner S, Chioni A M, Jarosz M, Rudling R, Cross B, Hart IR, Dickson C. The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development. EMBO J 2007; 26: 1268-1278.
14. Yang J, Meyer M, Müller A, Böhm F, Grose R, Dauwalder T, Verry F, Kopf M, Partanen J, Bloch W, Ornitz DM, Werner S. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. J Cell Biol 2010; 188: 935-952.
15. Maufort JP, Genther Williams SM, Pitot HC, Lambert PF. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res 2007; 67: 6106- 6112.
16. Rosenberger S, Thorey IS, Werner S, Boukamp P. A Novel Regulator of Telomerase. S100A8 mediates differentiationdependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT. J Biol Chem 2007; 282: 6126-6135.
17. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
18. Stanley MA, Browne HM, Appleby M, Minson AC. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 1989; 43: 672-676.
19. Pett MR, Alazawi WOF, Roberts I, Dowen S, Smith DI, Stanley MA, Coleman N. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 2004; 64: 1359-1368.
20. Gray E, Pett MR, Ward D, Winder DM, Stanley MA, Roberts I, Scarpini CG, Coleman N. In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrantassociated carcinogenesis. Cancer Res 2010; 70: 4081- 4091.
21. Ashrafi GH, Haghshenas MR, Marchetti B, o'brien PM, Campo MS. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int. J. Cancer 2005; 113: 276-83.
22. Belleudi F, Leone L, Aimati L, De Paola B, Cardinali G, Marchese C, Frati L, Picardo M, Torrisi MR. Endocytic pathways and biological effects induced by UVB-dependent or ligand-dependent activation of the keratinocyte growth factor receptor. FASEB J 2006; 20: 395-397.
23. Barbaresi S, Cortese MS, Quinn J, Ashrafi GH, Graham SV, Campo MS. Effects of human papillomavirus type 16E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain. J Gen Virol 2010; 91: 521-530.
24. Conrad M, Bubb VJ, Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 1993; 67: 6170-6178.
25. Kivi N, Greco D, Auvinen P, Auvinen E. Genes involved in cell adhesion, cell motility and mitogenic signalling are altered due to HPV 16 E5 protein expression. Oncogene 2008; 27: 2532-2541.
26. Greco D, Kivi N, Qian K, Leivonen S, Auvinen P, Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 2011; 6: e21646.
27. Candi E, Rufini A, Terrinoni A, Giamboi-Miraglia A, Lena AM, Mantovani R, Knight R, Melino G. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci USA 2007; 104: 11999-12004.
28. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008; 452: 225-229.
29. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, Candi E. miR-203 represses 'stemness' by repressing Np63. Cell Death Differ 2008; 15: 1187-1195.
30. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol 1990; 144: 326-332.
31. Marchese C, Felici A, Visco V, Lucania G, Igarashi M, Picardo M, Frati L, Torrisi MR. Fibroblast growth factor 10 induces proliferation and differentiation of human primary cultured keratinocytes. J Invest Dermatol 2001; 116: 623- 628.
32. Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 2010; 84: 5212-5221.
33. Wu G, Nomoto S, Hoque MO, Dracheva T, Osada M, Lee CC, Dong SM, Guo Z, Benoit N, Cohen Y, Rechthand P, Califano J et al. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 2003; 63: 2351-2357.
34. Candi E, Cipollone R, Rivetti di Val Cervo P, Gonfloni S, Melino G, Knight R. p63 in epithelial development. Cell Mol Life Sci 2008; 65: 3126-3133.
35. Ferone G, Thomason HA, Antonini D, De Rosa L, Hu B, Gemei M, Zhou H, Ambrosio R, Rice DP, Acampora D, van Bokhoven H, Del Vecchio L et al. Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome. EMBO Mol Med 2012; 4: 192-205.